These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24448210)

  • 21. Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes.
    Mansur RB; Fries GR; Subramaniapillai M; Frangou S; De Felice FG; Rasgon N; McEwen B; Brietzke E; McIntyre RS
    J Psychiatr Res; 2018 Dec; 107():128-135. PubMed ID: 30391805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.
    Jepson S; Vought B; Gross CH; Gan L; Austen D; Frantz JD; Zwahlen J; Lowe D; Markland W; Krauss R
    J Biol Chem; 2012 Jun; 287(26):22184-95. PubMed ID: 22514275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l.
    Llorens F; Gil V; Iraola S; Carim-Todd L; Martí E; Estivill X; Soriano E; del Rio JA; Sumoy L
    Dev Neurobiol; 2008 Mar; 68(4):521-41. PubMed ID: 18186492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal activity-induced regulation of Lingo-1.
    Trifunovski A; Josephson A; Ringman A; Brené S; Spenger C; Olson L
    Neuroreport; 2004 Oct; 15(15):2397-400. PubMed ID: 15640763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
    Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
    Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-LINGO-1 antibody treatment improves chronic stress-induced spatial memory impairments and oligodendrocyte loss in the hippocampus.
    Yang C; Tang J; Liang X; Qi Y; Luo Y; Xie Y; Wang J; Jiang L; Zhou C; Huang C; Tang Y
    Behav Brain Res; 2020 Sep; 393():112765. PubMed ID: 32535182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINGO-1 shRNA Loaded by Pluronic F-127 Promotes Functional Recovery After Ventral Root Avulsion.
    Ding L; Zhu Z; Wang Y; Zeng L; Wang T; Luo J; Zou TB; Li R; Sun X; Zhou G; Liu X; Wu HF
    Tissue Eng Part A; 2019 Oct; 25(19-20):1381-1395. PubMed ID: 30794055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINGO-1 Regulates Oligodendrocyte Differentiation through the Cytoplasmic Gelsolin Signaling Pathway.
    Shao Z; Lee X; Huang G; Sheng G; Henderson CE; Louvard D; Sohn J; Pepinsky B; Mi S
    J Neurosci; 2017 Mar; 37(12):3127-3137. PubMed ID: 28193690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.
    Park JB; Yiu G; Kaneko S; Wang J; Chang J; He XL; Garcia KC; He Z
    Neuron; 2005 Feb; 45(3):345-51. PubMed ID: 15694321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Nogo receptor inhibits proliferation, migration and axonal extension by transcriptionally regulating WNK1 in PC12 cells.
    Yang T; Zhao K; Shu H; Chen X; Cheng J; Li S; Zhao Z; Kuang Y; Yu S
    Neuroreport; 2017 Jun; 28(9):533-539. PubMed ID: 28489665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
    Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
    Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
    Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troy/Taj and its role in CNS axon regeneration.
    Mi S
    Cytokine Growth Factor Rev; 2008; 19(3-4):245-51. PubMed ID: 18524667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.
    Marklund N; Fulp CT; Shimizu S; Puri R; McMillan A; Strittmatter SM; McIntosh TK
    Exp Neurol; 2006 Jan; 197(1):70-83. PubMed ID: 16321384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Nogo receptor complex in diseases of the central nervous system.
    McDonald CL; Bandtlow C; Reindl M
    Curr Med Chem; 2011; 18(2):234-44. PubMed ID: 21110803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and Epigenetic Regulation in
    Andrews JL; Zalesky A; Nair S; Sullivan RP; Green MJ; Pantelis C; Newell KA; Fernandez F
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice.
    Sun JJ; Ren QG; Xu L; Zhang ZJ
    Sci Rep; 2015 Sep; 5():14235. PubMed ID: 26383267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fasudil reduces apoptosis of SH-SY5Y cells induced by H
    Guo M; Zhang H; Yu J; Zhang P; Wang Y; Wei W; Song L; Chai Z; Yu J; Ma C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jul; 38(7):625-631. PubMed ID: 35786457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence.
    Rudick RA; Mi S; Sandrock AW
    Expert Opin Biol Ther; 2008 Oct; 8(10):1561-70. PubMed ID: 18774923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.